NexThera Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2020-02-17
- Employees
- 51
- Market Cap
- -
- Website
- http://www.nexthera.org
NT-101 Topical Ophthalmic Solution in Patients With Wet AMD
Phase 1
Recruiting
- Conditions
- Wet Age Related Macular DegenerationWet AMD
- Interventions
- Drug: NT-101 0.05 mMDrug: NT-101 0.2 mM
- First Posted Date
- 2024-11-25
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- NexThera Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT06704009
- Locations
- 🇺🇸
Elman Retina Group, Rosedale, Maryland, United States
🇺🇸Duke Eye Center, Durham, North Carolina, United States
🇺🇸Erie Retina Research, Erie, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath